Table 1. Socio-demographic and clinical variables of study participants in Northern Red Sea region, 2014–2019 cohort (n = 1227).
Variable | Frequency | Percentage | |
---|---|---|---|
Sex (1225) | |||
Male | 671 | 54.8% | |
Female | 554 | 45.2% | |
Age range (1226) | |||
≤ 14 | 161 | 13.1% | |
15–24 | 202 | 16.5% | |
25–34 | 198 | 16.2% | |
35–44 | 217 | 17.7% | |
45–54 | 208 | 17.0% | |
55–64 | 142 | 11.6% | |
≥ 65 | 98 | 8.0% | |
Residence (1223) | |||
Urban | 705 | 57.6% | |
Rural | 518 | 42.4% | |
History of TB treatment | |||
New | 1157 | 94.3% | |
Previously treated | Relapse | 66 | 5.4% |
Treatment after failure | 2 | 0.2% | |
Treatment after lost to follow up | 2 | 0.2% | |
Type of TB | |||
Pulmonary TB (bacteriological confirmed) | 502 | 40.9% | |
Pulmonary TB (clinical diagnosed) | 332 | 27.1% | |
Extra-pulmonary TB (bacteriological confirmed) | 21 | 1.7% | |
Extra-pulmonary TB (clinical diagnosed) | 372 | 30.3% | |
TB treatment category | |||
Category-I | 1014 | 82.6% | |
Category-II | 70 | 5.7% | |
Category-III | 143 | 11.7% | |
HIV status (1226) | |||
Negative | 1208 | 98.5% | |
Positive | 18 | 1.5% | |
AFB sputum results at diagnosis | |||
Positive | 523 | 42.6% | |
Negative | 318 | 25.9% | |
NA | 386 | 31.5% | |
AFB sputum results at 2nd month(1224) | |||
Positive | 35 | 2.9% | |
Negative | 741 | 60.5% | |
NA | 448 | 36.6% | |
Health facility | |||
Afabet Hospital | 410 | 33.4% | |
Ghindae Regional Referral Hospital | 289 | 23.6% | |
Massawa Hospital | 345 | 28.1% | |
Nakfa Hospital | 183 | 14.9% |
N.B. Discrepancy in numbers is due to missing values